Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
CA 2498407 A1 · Owner: The Regents Of The University Of California · Inventors: Glabe, Charles G.; Kayed, Rakez
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions of matter that comprise one or more conformational epitopes found on amyloid peptide aggregates, antibodies to such epitopes and methods for making and using the compositions, eptitopes and/or antibodies. The invention includes synthetic or isolated compositions that contain or consist of certain conformational epitopes that are found on peptide aggregates (e.g. toxic peptide aggregates) present in human or veterinary patients who suffer from or who are likely to develop, amyloid diseases (e.g. Alzheimer's Disease). The invention includes methods for the detection treatment and prevention of , diseases in humans or animals using such compositions. The invention further …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 12, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 12, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 12, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.